Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

In re Yasmin and Yaz Drospirenone Marketing, Sales Practices and Products Liability Litigation

United States District Court, Seventh Circuit

June 20, 2013

IN RE YASMIN AND YAZ DROSPIRENONE MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION MDL No. 2100 This Document Relates to: Sandra Baker
v.
Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-11027-DRH-PMF Jade Crocker
v.
Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-11132-DRH-PMF Erica Fabian
v.
Bayer Corp., et al. No. 3:11-cv-10867-DRH-PMF Joyce Hawkins
v.
Bayer Corp., et al. No. 3:10-cv-12924-DRH-PMF Myranda Hinckley
v.
Bayer Corp., et al. No. 3:11-cv-12092-DRH-PMF Wendy Hudson
v.
Bayer Corp., et al. No. 3:11-cv-11689-DRH-PMF Charlotte McIntosh
v.
Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-11283-DRH-PMF Amanda Naquin
v.
Bayer Corp., et al. No. 3:11-cv-10981-DRH-PMF Christina Pietzak
v.
Bayer Corp., et al. No. 3:11-cv-10860-DRH-PMF Kristal Ramirez
v.
Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-12198-DRH-PMF Denise Sloan
v.
Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-11029-DRH-PMF Emily Smith
v.
Bayer Corp., et al. No. 3:11-cv-12025-DRH-PMF Tracy and Jeffrey Spangler
v.
Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-10691-DRH-PMF Nashlee Taylor
v.
Bayer Corp., et al. No. 3:11-cv-11645-DRH-PMF Susan Tedaldi
v.
Bayer Corp., et al. No. 3:11-cv-10837-DRH-PMF Monica Thompson
v.
Bayer Corp., et al. No. 3:11-cv-12029-DRH-PMF Misty Tyson
v.
Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:10-cv-12678-DRH-PMF Debra West
v.
Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-11735-DRH-PMF

ORDER DISMISSING WITH PREJUDICE

David R. Herndon Chief Judge United States

This matter is before the Court on the defendant Bayer HealthCare Pharmaceuticals Inc.’s motion, pursuant to Case Management Order 12 (“CMO 12”), for an order dismissing the plaintiffs’ claims, in the above-captioned matters, with prejudice for failure to comply with Plaintiff Fact Sheet (“PFS”) obligations.

On February 9, 2012, Bayer HealthCare Pharmaceuticals Inc. moved to dismiss the above captioned matters without prejudice for failure to comply with PFS obligations. The Court granted the motion on March 1, 2012

In the order dismissing the above captioned actions, the Court warned the plaintiffs that, “pursuant to CMO 12 Section E, unless plaintiffs serve defendants with a COMPLETED PFS or move to vacate the dismissal without prejudice within 60 days after entry of this Order, the Order will be converted to a Dismissal With Prejudice upon defendants’ motion.”

On April 2, 2013, more than one year after the entry of the order of dismissal without prejudice, Bayer HealthCare Pharmaceuticals Inc. filed the subject motion stating the plaintiffs are still not in compliance with their PFS obligations and asking the Court to convert the dismissals to dismissals with prejudice pursuant to Section E of CMO 12,

To date, none of the above captioned plaintiffs have taken any steps to cure their PFS deficiencies, to address the without prejudice dismissal, or to reply to the motion for dismissal with prejudice. The plaintiffs have had ample time to cure the any PFS deficiencies and avoid a with prejudice dismissal.

Having considered the motion and the relevant provisions of CMO 12 the Court ORDERS as follows:

The plaintiffs in the above captioned actions have failed to comply with their obligations pursuant to CMO 12 and more than 60 days have passed since the entry of the order of dismissal without prejudice for failure to comply with CMO 12. Accordingly, pursuant to Section E of CMO 12, the plaintiffs’ complaints are hereby dismissed WITH prejudice.

Further, the Court DIRECTS the Clerk of the Court to enter judgment reflecting the same.

SO ORDERED


Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.